NRobotics Co (138360.KQ) Stock Price

Hyupjin Co., Ltd. generates revenue through the manufacture and sale of cosmetic ingredients, including bioconversion technology products, encapsulated products, natural extracts, and synthetic products. Key products such as Aquatouch L, Silkytouch L, Phytoact Reliefer, PhytoAct CosyPlex, Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir, and Actosome Deage are sold to clients in the cosmetics industry. The company provides electronic materials as part of its product portfolio, targeting manufacturers seeking high-quality cosmetic ingredients and materials for their formulations. Hyupjin Co., Ltd. focuses on delivering specialized cosmetic ingredients through its range of products, with each product composed of specific ingredients like glycerin, dimethicone, water, lecithin, and various plant extracts. The company’s offerings cater to the needs of cosmetic manufacturers who require advanced formulations for skincare and beauty products. Its product lineup includes both natural and synthetic options, supporting diverse applications in the beauty sector. The company’s product portfolio includes Aquatouch L, Silkytouch L, and multiple Actosome series products, all designed to meet the demands of cosmetic manufacturers. These products are formulated with ingredients such as phaseolus radiates seed extract, avena sativa meal extract, and ethyhexylglycerin, among others. Hyupjin Co., Ltd. serves the cosmetics industry by providing ingredients that enhance product performance and consumer appeal, leveraging its bioconversion technology and natural extract expertise.